Načítá se...
Aerosolized PGE(1): A Selective Pulmonary Vasodilator in Neonatal Hypoxemic Respiratory Failure Results of a Phase I/II Open Label Clinical Trial
OBJECTIVE: Phase I/II feasibility, safety and dose escalation study of inhaled PGE(1) (IPGE(1)) in neonatal hypoxemic respiratory failure. DESIGN/METHODS: Twenty term/near term neonates with hypoxemic respiratory failure and oxygenation index ≥ 20 were enrolled. IPGE(1) was delivered by a jet nebuli...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2004
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1237020/ https://ncbi.nlm.nih.gov/pubmed/15295081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1203/01.PDR.0000139927.86617.B6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|